miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein
Yaqiang Huang(Sun Yat-sen University), Shaopeng Qiu(The First Affiliated Hospital, Sun Yat-sen University)
Cited by 27
Related Papers
Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K
|Journal of Cancer|2016|78